日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Trial Design and Objectives for Patients With Prostate Cancer: Recommendations From the Prostate Cancer Working Group 4

前列腺癌患者的试验设计和目标:前列腺癌工作组4的建议

Armstrong, Andrew J; Morris, Michael J; Abida, Wassim; Aggarwal, Rahul R; Antonarakis, Emmanuel S; Attard, Gerhardt; Beltran, Himisha; Bryce, Alan; Carducci, Michael A; Cheng, Heather H; Chen, Delphine L; Chi, Kim N; Childs, Daniel S; Dahut, William; Emmett, Louise; Fizazi, Karim; Gafita, Andrei; George, Daniel J; Hermann, Ken; Hofman, Michael S; Hope, Thomas; Hussain, Maha; Kelly, W Kevin; Kessler, Elizabeth; Kuo, Phillip H; Lang, Joshua; Liu, Glenn; Marshall, Catherine H; Morgans, Alicia K; McKay, Rana R; Nanus, David; Nelson, Peter; Paller, Channing; Reichert, Zachery R; Ryan, Charles J; Sartor, A Oliver; Schöder, Heiko; Schwartz, Lawrence H; Sharifi, Nima; Stadler, Walter M; Stein, Mark; Sternberg, Cora N; Szmulewitz, Russell Z; Tagawa, Scott T; Sokolova, Alexandra O; Wyatt, Alex W; Yamoah, Kosj; Yu, Evan Y; Halabi, Susan; Scher, Howard I

Optimal Duration of Androgen Deprivation Therapy With Definitive Radiotherapy for Localized Prostate Cancer: A Meta-Analysis

局部前列腺癌根治性放疗联合雄激素剥夺疗法的最佳疗程:一项荟萃分析

Zaorsky, Nicholas G; Sun, Yilun; Nabid, Abdenour; Zapatero, Almudena; Bolla, Michel; Joseph, David; Maingon, Philippe; Guerrero, Araceli; Gonzalez, Ana Alvarez; San-Segundo, Carmen Gonzalez; Cabeza Rodríguez, Maria Ángeles; Sole, Josep Maria; Olivé, Agustí Pedro; Steigler, Allison; Souhami, Luis; Carrier, Nathalie; Armstrong, John G; Gillham, Charles; Pisansky, Thomas M; Schipper, Matthew; Sandler, Howard M; Efstathiou, Jason A; Lawton, Colleen; de Reijke, Theo M; Attard, Gerhardt; Roy, Soumyajit; Morgan, Scott C; Malone, Shawn; Hall, William A; Nguyen, Paul L; Shoag, Jonathan E; Vince, Randy A Jr; Calaway, Adam; Garcia, Jorge A; Barata, Pedro C; Mendiratta, Prateek; Brown, Jason R; Valle, Luca; Rettig, Matthew; Dess, Robert T; Jackson, William C; Martin, Ting; Jia, Angela Y; Steinberg, Michael; Romero, Tahmineh; Kishan, Amar U; Spratt, Daniel E

The global cancer crisis: a review of growing burden, deepening inequality and initiatives for prevention and early detection

全球癌症危机:日益加重的负担、日益加剧的不平等以及预防和早期检测举措综述

Balch, Charles M; Liao, Ning; Lam, Dennis S C; Weitzel, Jeffrey N; Xu, Rui-Hua; Attard, Gerhardt; Bunn, Paul A; Eggermont, Alexander M M; He, Jie; Kitagawa, Yuko; Lim, Soon Thye; Cazap, Eduardo; Esquivel, Bernard; Fan, Xianqun; Chow, Louis W C; Liu, Edward S F; Said, Hector Martinez; Niederhuber, John E; Rubio, Isabel T; Zaghloul, Ashraf Saad; Arrieta, Oscar G; Audisio, Riccardo A; Beets, Geerard L; Coimbra, Felipe J F; Gallardo, Jorge E; Garber, Judy E; Gronchi, Alessandro; Heinemann, Volker; Kurian, Allison W; Mutebi, Miriam; Mori, Masaki; Olopade, Funmi I; Rutkowski, Piotr; Saleh, Mansoor; Sanchez, William M; Sawaya, Raymond; Thompson, John F; Tumusiime, Gerald; Vallejos, Carlos S; Whiteman, David C; Wu, YiLong; Yawe, King-David T; Zahrani, Nayef Awad Al; Zoras, Odysseas; Arun, Banu K; Fabian, Carol J; Gershenwald, Jeffrey E; Gradishar, William J; He, Jin; Kimberg, V Suzanne; Lam, Ronald M K; Lee, Victor H F; Lorusso, Domenica; Mok, Tony S K; Perrier, N D; Rugo, Hope S; Ulrich, Cornelia; Are, Chandrakanth; Vignat, J; Soerjomataram, I

Niraparib and abiraterone acetate plus prednisone for HRR-deficient metastatic castration-sensitive prostate cancer: a randomized phase 3 trial

尼拉帕尼和醋酸阿比特龙联合泼尼松治疗HRR缺陷型转移性去势敏感性前列腺癌:一项随机3期试验

Attard, Gerhardt; Agarwal, Neeraj; Graff, Julie N; Sandhu, Shahneen; Efstathiou, Eleni; Özgüroğlu, Mustafa; Pereira de Santana Gomes, Andrea J; Vianna, Karina; Luo, Hong; Gotto, Geoffrey T; Cheng, Heather H; Kim, Won; Varela, Carly R; Schaeffer, Daneen; Kramer, Kassie; Li, Susan; Baron, Benoit; Shen, Fei; Mundle, Suneel D; McCarthy, Sharon A; Olmos, David; Chi, Kim N; Rathkopf, Dana E

Metformin for patients with metastatic prostate cancer starting androgen deprivation therapy: a randomised phase 3 trial of the STAMPEDE platform protocol

二甲双胍用于开始接受雄激素剥夺疗法的转移性前列腺癌患者:STAMPEDE平台方案的随机3期试验

Gillessen, Silke; Murphy, Laura; James, Nicholas D; Sachdeva, Ashwin; El-Taji, Omar; Abdel-Aty, Hoda; Adler, Amanda I; Amos, Claire; Attard, Gerhardt; Varughese, Mohini; Gale, Joanna; Brown, Simon; Srihari, Narayanan; Birtle, Alison J; Brown, Mick; Chan, Kitty; Chowdhury, Simon; Cross, William; Dearnaley, David P; Din, Omar; Dutey-Magni, Peter; Gilbert, Duncan C; Gilson, Clare; Gray, Struan; Grist, Emily; Hofmann, Uschi; Hudson, Andrew M; Jain, Yatin; Jeyasangar, Ganesan; Jones, Robert; Kayani, Mahaz; Langley, Ruth E; Malik, Zafar; Mason, Malcolm D; Matheson, David; McAlpine, Connor; Macnair, Archie; Millman, Robin; Murphy, Claire; Padden-Modi, Minal; Parikh, Omi; Parker, Chris; Rush, Hannah; Russell, Martin; Srinivasan, Rajaguru; Sundar, Santhanam; Tanguay, Jacob S; Turco, Fabio; Williams, Patrick; Sydes, Matthew R; Parmar, Mahesh K B; Brown, Louise C; Clarke, Noel W

Plasma AR Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer: the STAMPEDE Phase 3 Randomized Clinical Trial

血浆雄激素受体(AR)改变与前列腺癌强化激素治疗时机的关系:STAMPEDE III期随机临床试验

Leone, Gianmarco; Orlando, Francesco; Dutey-Magni, Peter; Vainauskas, Osvaldas; Grist, Emily; Ciani, Yari; Lall, Sharanpreet; Thakali, Suparna; Wingate, Anna; Wetterskog, Daniel; Sachdeva, Ashwin; Sydes, Matthew R; McPhail, Neil; Sreenivasan, Thiagarajan; O'Sullivan, Joe M; Clarke, Noel W; Parmar, Mahesh K B; Brown, Louise C; James, Nicholas D; Demichelis, Francesca; Attard, Gerhardt

Uncovering phenotypic heterogeneity through research autopsy in lethal prostate cancer

通过对致命性前列腺癌患者进行尸检研究,揭示其表型异质性

Chan, Sylvie Sw; Vainauskas, Osvaldas; Attard, Gerhardt

Clinical Context Shapes the Relationship between Genomic Alterations and Response to AR Inhibitors and Chemotherapy in Metastatic Prostate Cancer.

临床背景决定了转移性前列腺癌中基因组改变与 AR 抑制剂和化疗反应之间的关系

Shah Kalpit, Secrest Matthew H, Zhou Wei, Wang Shu, Canter Dan, Zhang Yuxiang, Jin Dexter, Sokol Ethan, Nowicka Malgorzata, Ang Houle Armande, Metcalfe Ciara, Gendreau Steven, Schröder Carsten, Wongchenko Matthew, Attard Gerhardt

Transcriptomic Analysis of Localized High-risk Prostate Cancer Improves Prognostication and Identifies Benefit from Adding Docetaxel to Definitive Radiotherapy with Androgen Suppression in the NRG Oncology/RTOG 0521 Phase 3 Trial

NRG Oncology/RTOG 0521 3期试验表明,局部高危前列腺癌的转录组分析可改善预后,并揭示在根治性放疗联合雄激素抑制治疗中加入多西他赛的益处。

Phillips, Ryan M; Proudfoot, James A; Davicioni, Elai; Liu, Yang; Spratt, Daniel E; Simko, Jeff M; Den, Robert B; Pollack, Alan; Rosenthal, Seth A; Sartor, A Oliver; Sweeney, Christopher J; Attard, Gerhardt; Longoria, Leslie; Patel, Samir; Straza, Michael W; Efstathiou, Jason A; Shah, Amit B; Hoffman, Karen E; Rodgers, Joseph P; Sandler, Howard M; Feng, Felix Y; Tran, Phuoc T

Digital Pathology-based Artificial Intelligence Biomarker Validation in Metastatic Prostate Cancer

基于数字病理学的人工智能生物标志物在转移性前列腺癌中的验证

Markowski, Mark C; Ren, Yi; Tierney, Meghan; Royce, Trevor J; Yamashita, Rikiya; Croucher, Danielle; Huang, Huei-Chung; Todorovic, Tamara; Chen, Emmalyn; Showalter, Timothy N; Carducci, Michael A; Chen, Yu-Hui; Liu, Glenn; Parker, Charles T A; Esteva, Andre; Feng, Felix Y; Attard, Gerhardt; Sweeney, Christopher J